Chengbing Zeng YOU? Author Swipe

Last 10y

Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients Open

Jianzhou Chen, Antonin Lévy, Ai-Ling Tian, Xuehan Huang, Guoxin Cai , et al. · 2025

Radiomics signature for dynamic changes of tumor-infiltrating CD8+ T cells and macrophages in cervical cancer during chemoradiotherapy Open

Kang Huang, Xuehan Huang, Chengbing Zeng, Siyan Wang, Yizhou Zhan , et al. · 2024

Data from Heterogeneity of IFN-Mediated Responses and Tumor Immunogenicity in Patients with Cervical Cancer Receiving Concurrent Chemoradiotherapy Open

Jianzhou Chen, Chuangzhen Chen, Yizhou Zhan, Li Zhou, Jie Chen , et al. · 2023

Purpose:To ask whether the expression of immune markers and IFN signaling in tumor biopsies changes during concurrent chemoradiotherapy (CCRT).Experimental Design:Tumor biopsies and peripheral mononuclear blood cells (PMBC) before and imme…

Supplementary Data from Heterogeneity of IFN-Mediated Responses and Tumor Immunogenicity in Patients with Cervical Cancer Receiving Concurrent Chemoradiotherapy Open

Jianzhou Chen, Chuangzhen Chen, Yizhou Zhan, Li Zhou, Jie Chen , et al. · 2023

Table S1-S7

Supplementary Data from Heterogeneity of IFN-Mediated Responses and Tumor Immunogenicity in Patients with Cervical Cancer Receiving Concurrent Chemoradiotherapy Open

Jianzhou Chen, Chuangzhen Chen, Yizhou Zhan, Li Zhou, Jie Chen , et al. · 2023

Table S1-S7

Supplementary Data from Heterogeneity of IFN-Mediated Responses and Tumor Immunogenicity in Patients with Cervical Cancer Receiving Concurrent Chemoradiotherapy Open

Jianzhou Chen, Chuangzhen Chen, Yizhou Zhan, Li Zhou, Jie Chen , et al. · 2023

Figure S1-S14

Supplementary Data from Heterogeneity of IFN-Mediated Responses and Tumor Immunogenicity in Patients with Cervical Cancer Receiving Concurrent Chemoradiotherapy Open

Jianzhou Chen, Chuangzhen Chen, Yizhou Zhan, Li Zhou, Jie Chen , et al. · 2023

Figure S1-S14

Data from Heterogeneity of IFN-Mediated Responses and Tumor Immunogenicity in Patients with Cervical Cancer Receiving Concurrent Chemoradiotherapy Open

Jianzhou Chen, Chuangzhen Chen, Yizhou Zhan, Li Zhou, Jie Chen , et al. · 2023

Purpose:To ask whether the expression of immune markers and IFN signaling in tumor biopsies changes during concurrent chemoradiotherapy (CCRT).Experimental Design:Tumor biopsies and peripheral mononuclear blood cells (PMBC) before and imme…

A combined predicting model for benign esophageal stenosis after simultaneous integrated boost in esophageal squamous cell carcinoma patients (GASTO1072) Open

Weitong Liu, Chengbing Zeng, Siyan Wang, Yizhou Zhan, Ruihong Huang , et al. · 2022

Purpose We aimed to develop a combined predicting model for benign esophageal stenosis (BES) after simultaneous integrated boost (SIB) with concurrent chemotherapy in patients with esophageal squamous cell carcinoma (ESCC). Methods This st…

Radiomics models based on CT at different phases predicting lymph node metastasis of esophageal squamous cell carcinoma (GASTO-1089) Open

Guobo Peng, Yizhou Zhan, Yanxuan Wu, Chengbing Zeng, Siyan Wang , et al. · 2022

Purpose To investigate the value of radiomics models based on CT at different phases (non-contrast-enhanced and contrast-enhanced images) in predicting lymph node (LN) metastasis in esophageal squamous cell carcinoma (ESCC). Methods and ma…

A Combined Model to Improve the Prediction of Local Control for Lung Cancer Patients Undergoing Stereotactic Body Radiotherapy Based on Radiomic Signature Plus Clinical and Dosimetric Parameters Open

Limei Luo, Bao-Tian Huang, Chuangzhen Chen, Ying Wang, Chuang-Huang Su , et al. · 2022

Purpose Stereotactic body radiotherapy (SBRT) is an important treatment modality for lung cancer patients, however, tumor local recurrence rate remains some challenge and there is no reliable prediction tool. This study aims to develop a p…

Late Toxicities, Failure Patterns, Local Tumor Control, and Survival of Esophageal Squamous Cell Carcinoma Patients After Chemoradiotherapy With a Simultaneous Integrated Boost: A 5-Year Phase II Study Open

Chuangzhen Chen, Jianzhou Chen, Ting Luo, Siyan Wang, Hong Guo , et al. · 2021

Purpose We aimed to evaluate the long-term outcomes of concurrent chemoradiotherapy (CCRT) with a simultaneous integrated boost (SIB) of radiotherapy for esophageal squamous cell carcinoma (ESCC). Methods and Materials Eighty-seven patient…

Heterogeneity of IFN-Mediated Responses and Tumor Immunogenicity in Patients with Cervical Cancer Receiving Concurrent Chemoradiotherapy Open

Jianzhou Chen, Chuangzhen Chen, Yizhou Zhan, Li Zhou, Jie Chen , et al. · 2021

Purpose: To ask whether the expression of immune markers and IFN signaling in tumor biopsies changes during concurrent chemoradiotherapy (CCRT). Experimental Design: Tumor biopsies and peripheral mononuclear blood cells (PMBC) before and i…

Imaging biomarkers of contrast-enhanced computed tomography predict survival in oesophageal cancer after definitive concurrent chemoradiotherapy Open

Chengbing Zeng, Tian‐Tian Zhai, Jianzhou Chen, Longjia Guo, Bao-Tian Huang , et al. · 2021

Imaging biomarkers of contrast-enhanced computed tomography predict survival in oesophageal cancer after definitive concurrent chemoradiotherapy Open

Chengbing Zeng, Tian‐Tian Zhai, Jianzhou Chen, Longjia Guo, Bao-Tian Huang , et al. · 2020

Background: This study aimed to evaluate the predictive potential of contrast-enhanced computed tomography (CT)-based imaging biomarkers (IBMs) for the treatment outcomes of patients with oesophageal squamous cell carcinoma (OSCC) after de…

Imaging biomarkers of contrast-enhanced computed tomography predict survival in oesophageal cancer after definitive concurrent chemoradiotherapy Open

Chengbing Zeng, Tian‐Tian Zhai, Jianzhou Chen, Longjia Guo, Bao-Tian Huang , et al. · 2020

Background: This study aimed to evaluate the predictive potential of contrast-enhanced computed tomography (CT)-based imaging biomarkers (IBMs) for the treatment outcomes of patients with oesophageal squamous cell carcinoma (OSCC) after de…

Imaging biomarkers of contrast-enhanced computed tomography predict survival in oesophageal cancer after definitive concurrent chemoradiotherapy Open

Chengbing Zeng, Tian‐Tian Zhai, Jianzhou Chen, Longjia Guo, Bao-Tian Huang , et al. · 2020

Background: This study aimed to evaluate the predictive potential of contrast-enhanced computed tomography (CT)-based imaging biomarkers (IBMs) for the treatment outcomes of oesophageal squamous cell carcinoma (OSCC) patients after definit…

Imaging Biomarkers of Contrast-enhanced Computed Tomography Predict Survival in Oesophageal Cancer After Definitive Concurrent Chemoradiotherapy Open

Chengbing Zeng, Tian‐Tian Zhai, Jianzhou Chen, Longjia Guo, Bao-Tian Huang , et al. · 2020

Background: This study aimed to evaluate the predictive potential of contrast-enhanced computed tomography (CT)-based imaging biomarkers (IBMs) for the treatment outcomes of oesophageal squamous cell carcinoma (OSCC) patients after definit…

Fetching topic information...